The Discounted Cash Flow (DCF) valuation of Oramed Pharmaceuticals Inc (ORMP) is (111.04) USD. With the latest stock price at 2.60 USD, the upside of Oramed Pharmaceuticals Inc based on DCF is -4370.6%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.9% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (429.52) - (64.64) | (111.04) |
| Upside | -16620.0% - -2586.2% | -4370.6% |